Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04204304Completed
Open-label trial of isotretinoin in acne vulgaris (2 arms), sponsored by Ankara Training and Research Hospital. Primary endpoints: Musculoskeletal adverse effects in isotretinoin receiving patients at 2 days and Serum 25 hydroxy vitamin D level at 7 days. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04204304.